US87166L2097 - Common Stock
SYNLOGIC INC
NASDAQ:SYBX (5/1/2024, 7:24:36 PM)
1.9
+0.11 (+6.15%)
Synlogic Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Cambridge, Massachusetts and currently employs 72 full-time employees. The company went IPO on 2015-09-30. Synlogic, Inc. is a clinical-stage biopharmaceutical company. The firm is engaged in advancing therapeutics based on synthetic biology. Its pipeline includes its program in phenylketonuria (PKU), and additional drug candidates designed to treat homocystinuria (HCU), enteric hyperoxaluria and gout. The firm uses programmable, precision genetic engineering of well-characterized probiotics to exert localized activity for therapeutic benefit, with a focus on metabolic and immunological diseases. The firm also has a research collaboration with Roche on the discovery of a novel Synthetic Biotic for the treatment of inflammatory bowel disease (IBD). The firm has also developed two drug candidates through a research collaboration with Ginkgo Bioworks, Inc: SYNB1353, designed to consume methionine for the potential treatment of homocystinuria (HCU), and SYNB2081, designed to lower uric acid for the potential treatment of gout.
SYNLOGIC INC
301 Binney St Ste 402
Cambridge MASSACHUSETTS 02142
P: 16174019975
CEO: Aoife Brennan
Employees: 72
Website: https://www.synlogictx.com/
CAMBRIDGE, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform...
Engages Ladenburg Thalmann as financial advisor to assist with previously announced strategic review process
Engages Ladenburg Thalmann as financial advisor to assist with previously announced strategic review process...
Synlogic (SYBX) stock was trading nearly 50% lower midday Friday, the day after the company announced it was pulling the plug on its lead drug program and shutting down operations.
CleanSpark stock is rising higher on Friday as investors in CLSK shares celebrate the company's positive Q1 earnings report.
Here you can normally see the latest stock twits on SYBX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: